innocells investment thesis

InnoCells investment thesis

Tl;dr: The investment thesis of InnoCells which is the corporate venture arm and digital innovation hub of Banco Sabadell. InnoCells investment thesis In the height of the fintech revolution, it is essential for banks to be connected to the startup ecosystem in order to adequately approach the new challenges and opportunities that are being presented to the financial sector.  From increasingly …

ExSight Ventures Investment Thesis

ExSight Investment Thesis

Tl;dr: Investment thesis of ExSight which invests in eyes. To be honest, I’m adding this because it’s a weird one. I don’t even see that they have a fund, but they are active having done 8 deals and had one exit. ​ExSight’s Investment Thesis ​Drawing on our unique domain expertise and utilizing capital efficient techniques, ExSight invests in early-stage companies …

Allied Venture Partners Investment Thesis

Allied Venture Partners Investment Thesis

Tl;dr: Allied Venture Partners is an angel group rather than a fund. They have a 6-factor investment thesis. Allied Venture Partners is one of Canada’s largest angel investor groups. Our mission is to grow and diversify Western Canada’s technology startup ecosystem by providing local investors with venture-scale investment opportunities from established VC markets, while providing local entrepreneurs with experienced outside …

a16z bio Investment Thesis

a16z bio investment thesis

Tl;dr: The investment thesis for a16z bio. This is the biotech fund from Andreeson Horrowitz. So a16z have an investment thesis for all their funds, only they’re rubbish. At most there is a grunt of two sentences. The biotech fund was the only one with any content to it. Here is their fintech investment thesis for example and this is …

Mammoth scientific investment thesis

Mammoth Scientific Investment Thesis

Tl;dr: Investment thesis for Mammoth Scientific which is focused on life science and bio tech companies. They raised their first fund of $100m. Mammoth Scientific invests in early to growth-stage life science and biotech companies. We seek to add value through a deep functional understanding of healthcare delivery, contracting, private and CMS reimbursement, creation of new CMS reimbursement pathways, FDA, …